Public-registry site landscape for NCT03207906, a Chemotherapy-Associated Paronychia study sponsored by Veloce BioPharma LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03207906 (registry record) |
| Sponsor | Veloce BioPharma LLC |
| Condition(s) | Chemotherapy-Associated Paronychia |
| Phase | PHASE2 |
| Listed sites | 8 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT03207906 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →